UniProt P50549
P50549
P50549 (UniProt P50549): 6 experimental structures and 1 predicted model on GenesisL1. Binding sites, druggability and experiment against prediction (TM-score) in GL1X.
- UniProt
- P50549
- Experimental structures
- 6
- Predicted models
- 1
Structures
7 records of P50549 in the MolNFT archive: 6 experimental, 1 predicted.
| Entry | Title | Method | Chains | Ligands | Pockets |
|---|---|---|---|---|---|
| 4AVP | Crystal structure of the DNA-binding domain of human ETV1. | x-ray diffraction | A, B, C, D | — | — |
| 4AVP | Crystal structure of the DNA-binding domain of human ETV1. | x-ray diffraction | A, B, C, D | — | — |
| 4BNC | Crystal structure of the DNA-binding domain of human ETV1 complexed with DNA | x-ray diffraction | A | — | — |
| 4BNC | Crystal structure of the DNA-binding domain of human ETV1 complexed with DNA | x-ray diffraction | A | — | — |
| 5ILS | Autoinhibited ETV1 | x-ray diffraction | A | — | — |
| 5ILS | Autoinhibited ETV1 | x-ray diffraction | A | — | — |
| P50549 | AlphaFold monomer V2.0 prediction for ets translocation variant 1 (P50549) | predicted | A | — | — |
Experiment against prediction
- 4AVP chain B against the predicted model P50549: TM-score 0.97, RMSD 0.62 Å
- 4AVP chain B against the predicted model P50549: TM-score 0.97, RMSD 0.62 Å
- 5ILS chain A against the predicted model P50549: TM-score 0.97, RMSD 0.72 Å
- 5ILS chain A against the predicted model P50549: TM-score 0.97, RMSD 0.72 Å
- 4AVP chain C against the predicted model P50549: TM-score 0.97, RMSD 0.67 Å
- 4AVP chain C against the predicted model P50549: TM-score 0.97, RMSD 0.67 Å
- 4BNC chain A against the predicted model P50549: TM-score 0.96, RMSD 0.77 Å
- 4BNC chain A against the predicted model P50549: TM-score 0.96, RMSD 0.77 Å
- 4AVP chain A against the predicted model P50549: TM-score 0.96, RMSD 0.78 Å
- 4AVP chain A against the predicted model P50549: TM-score 0.96, RMSD 0.78 Å
Elsewhere
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.